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Abstract.  The chicken gene encoding cardiac troponin 
T  (cTNT) is expressed in both cardiac and skeletal 
muscle during early embryonic development, but is 
specifically repressed in skeletal muscle during  fetal 
development.  To determine  if the cis-acting  sequences 
governing transcription  of a  single gene in these two 
related cell types are the same,  we have transfected 
promoter/upstream  segments of the cTNT gene cou- 
pled to the bacterial chloramphenicol  acetyltransferase 
gene into primary cultures of early embryonic cardiac 
and  skeletal muscle cells.  Using this assay system, 
chloramphenicol acetyltransferase activity directed by 
the cTNT promoter/upstream  region was between two 
and three orders of magnitude higher in cardiac or 
skeletal muscle cells than  in fibroblast cells,  indicating 
that cis elements responsible for cell-specific expres- 
sion reside in this region of the cTNT gene.  Deletion 
experiments showed that a 67-nucleotide DNA seg- 
ment residing between 268 and 201  nucleotides up- 
stream of the cTNT transcription  initiation  site is re- 
quired for cTNT promoter activity in embryonic 
cardiac cells. This region is not required in embryonic 
skeletal muscle cells because a cTNT promoter con- 
struction containing only  129 upstream nucleotides is 
transcriptionally  active in these cells. These results 
demonstrate that different cis-acting  sequences are re- 
quired for cTNT expression in early embryonic cardiac 
and skeletal muscle cells.  Nonessential regions resid- 
ing farther upstream,  on the other hand,  affected the 
level of expression of these minimum  regions in a 
similar manner  in both cell types. The data from these 
experiments indicate,  therefore, that transcription  of 
the cTNT promoter in early embryonic cardiac and 
skeletal muscle cells is governed both by common and 
divergent regulatory elements in cis and in trans. 
C 
ARDIAC and skeletal muscle cells are the two types of 
striated muscle cells. Both share a remarkable degree 
of similarity  in terms of their sarcomere and myofila- 
ment structure,  strongly  suggesting  that  they arose during 
evolution from a common ancestral  cell type.  Despite their 
underlying  similarity,  cardiac,  and skeletal muscle are mor- 
phologically and physiologically  distinct  from one another. 
In addition,  the genes encoding cardiac and skeletal muscle 
contractile  proteins,  while clearly evolutionarily  related,  are 
distinct.  Vandekerckhove  and Weber (62)  indicate  that  the 
cardiac and skeletal actin isoproteins  diverged  from a com- 
mon cardiac-actin-like  ancestral  gene before the appearance 
of reptiles. Therefore, the divergence of these two related cell 
lineages  must have been an ancient one. 
During embryonic development, however, skeletal muscle 
cells exhibit many characteristics  which are similar to those 
of cardiac cells.  For example,  like cardiac cells,  embryonic 
skeletal muscle cells are intrinsically  and rhythmically  con- 
tractile,  and individual cells are electrically coupled to their 
neighbors  via gap junctions (37). Most intriguing,  perhaps, 
are the recent observations that embryonic skeletal muscles 
express "cardiac-specific"  isoforms  of actin  (3, 30, 34, 50, 
56),  myomesin (2),  and troponins  C  and  T  (11, 12,  60). 
Thus,  embryonic development of skeletal  muscle cells en- 
tails the expression of genes and phenotypic traits which are 
characteristic  of cardiac cells. It is not yet clear whether ex- 
pression of cardiac genes in early embryonic skeletal muscle 
represents  a vestigial gene regulatory mechanism due to the 
common ancestry of these two cell types, or a specific de- 
velopmental  requirement  met by the cardiac gene products. 
To begin  to understand  the mechanisms  which regulate 
genes in  embryonic cardiac and  skeletal  muscle cells,  we 
have begun to analyze the cis elements  governing transcrip- 
tion of individual genes transfected into both cell types. The 
cis elements  which govern expression of contractile  protein 
genes in skeletal muscle cells are beginning  to be identified 
using  this  approach.  For example,  transcription  of sarco- 
meric actin genes transfected  into skeletal  muscle cells ap- 
pears to depend on DNA sequences residing  within,  or up- 
stream of, their transcriptional  promoters (28, 47, 50, 51). On 
the other hand intragenic  DNA sequences have been impli- 
cated in the cell specific regulation of the troponin I gene (40) 
and in the muscle specific repression of the thymidine kinase 
gene (48). The mechanism(s)  by which these DNA segments 
govern skeletal muscle specific transcription is not yet known. 
Cell specific transcription  of many eukaryotic genes has been 
shown to be governed by cell-specific enhancer elements  (9, 
15,  16, 21, 29, 32), and in a few instances,  by cell specific 
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quence elements in contractile protein genes have been im- 
plicated in cell specific regulation due to their location within 
or near promoter regions (5, 36, 40, 50, 53, 55). Kedes and 
coworkers have shown that a conserved CCArGG motif  is re- 
quired for efficient expression of the human cardiac actin 
gene in skeletal muscle cells (50, 51). Conserved sequence 
elements have been shown to act as binding sites for common 
regulatory factors. In the analysis of contractile protein gene 
regulation, conserved sequence elements are of  particular in- 
terest because they may explain the apparent co-expression 
of diverse genes within a single muscle type as well as be- 
tween muscle types. 
There is no information to indicate whether the cis ele- 
ments governing gene expression in skeletal muscle cells are 
similar to or different from those operating in cardiac muscle 
cells.  Indeed, there has been little experimental work on 
cardiac specific gene expression, partly due to the lack of a 
myocardial cell line. For the present, therefore, analysis of 
cardiac specific gene regulatory elements can only be con- 
ducted  in primary cultures.  Morkin and colleagues have 
identified upstream regions which are required for the hor- 
mone responsiveness of the rat cardiac myosin heavy chain 
gene using transfection into primary cultures of rat neonatal 
myocardial cells (31). Here we have used transfection into 
primary cultures of chicken embryonic cardiac and skeletal 
muscle cells to identify the cis elements required for expres- 
sion of one gene in both cell types. 
For these experiments We have chosen to study the chicken 
gene encoding the cardiac form of troponin T (cTNT). ~  The 
cTNT gene serves as a good model because it is transcrip- 
tionally activated at early stages of both embryonic cardiac 
and skeletal muscle development, and is expressed at similar 
levels in both cell types throughout early development (11). 
However,  at about day 14 of gestation the cTNT gene be- 
comes  transcriptionally  repressed  in  developing  skeletal 
muscle, while simultaneously being strongly upregulated in 
developing cardiac muscle (44).  All cTNT mRNAs share 
common 5' termini, demonstrating that all arise from tran- 
scripts initiated at the same two sites which are separated by 
three nucleotides, regardless of cell type or developmental 
stage (12). This makes the cTNT gene an attractive candidate 
to address the question of whether cardiac and skeletal myo- 
cytes share common or distinct transcriptional regulatory 
programs to activate transcription of a  single gene.  If the 
transcriptional regulatory programs are  shared,  we would 
expect the same cis control elements to govern cTNT gene 
transcription in both cell types. On the other hand, if the 
transcriptional regulatory programs are different, we would 
expect the requirements for cTNT promoter expression in the 
two cell types to differ. 
To differentiate between these hypotheses we have ana- 
lyzed the ability of the cTNT promoter and upstream regions 
to govern chloramphenicol acetyltransferase (CAT) expres- 
sion in transiently transfected embryonic cardiac and skeletal 
muscle cells. When placed in culture, both cell types consti- 
tutively express the endogenous cTNT gene (61, and our un- 
published observations). However,  because both cell types 
1. Abbreviations used in this paper: CAT, chloramphenicol acetyltransfer- 
ase; cTNT, cardiac troponin T; HSV, Herpes simplex virus; RSV-LTR, Rous 
sarcoma virus-long terminal  repeat;  STV,  standard trypsin versene; tk, 
thymidine kinase. 
take up exogenous DNA with widely differing efficiencies, 
we analyzed CAT gene expression both enzymatic.ally, in cell 
extracts, and on an individual cell basis, by immunocyto- 
chemistry. Using this approach, we then determined that the 
cTNT promoter/upstream region directs 2-3 orders of mag- 
nitude higher levels of CAT expression in cardiac and skele- 
tal muscle cells than in fibroblast cells. Transfection of 5' de- 
letion mutants showed further that different regions in cis are 
required for the activity of the cTNT promoter in these two 
striated muscle cell types.  The  requirement  for different 
regions in cis is consistent with the presence of different 
positive-acting regulatory factors in trans within both cell 
types.  Therefore, despite their molecular, morphological, 
and physiological similarities, embryonic and cardiac skele- 
tal myocytes use different regulatory programs to positively 
regulate expression of the cTNT gene. 
Materials and Methods 
Materials 
Restriction endonucleases and SI  nuclease were purchased through New 
England Biolabs (Beverly,  MA) or Boehringer-Manaheim (Indianapolis, 
IN) and were used according to the instructions from the manufacturers. Re- 
verse transcriptase was obtained from Life Sciences, Inc. (St. Petersburg, 
FL). Media and media components were obtained from the Cell Culture Fa- 
cility at the University of California (San Francisco, CA) or from Gibco 
Laboratories, (Grand Island, NY). Petal bovine serum was obtained through 
HyClone Laboratories (Logan, UT). Radioactive compounds were obtained 
from Amersham Corp. (Arlington, Heights, IL). Other materials were ob- 
tained as indicated below. 
Methods 
Recombinant DNA.  Protocols for restriction endonuclease digestion, gel 
electrophoresis, plasmid DNA preparations, DNA fragment isolation, and 
ligations were essentially as described in standard cloning manuals (45). 
Transformations ofEscherichia coli DH-5 were performed by the procedure 
described by Hanahan (33). 
Plasmid Constructions 
cTNT-CATPlasmids. The cloned cTNT gene (12) was trunca~l at nuclco- 
tide position +38 in exon 1 (all nucleotide positions are relative to transcrip- 
tion initiation site) by partial cleavage with Ava H followed by complete 
cleavage at an artificial Eco RI site located 3,000 nuclcotides upstream of 
the transcription initiation site. During the process of subcioning this seg- 
ment into a pUC 8 polylinker the Ava II site was destroyed. The cTNT frag- 
ment was subsequently excised from this plasmid by Hind III digestion and 
cloned into the Hind Ill site of pBR-CAT (63) to fuse the truncated cTNT 
untranslated region with the untranslated region of CAT via a polylinker. 
This plasmid is designated cTNT-3,000 and served as the starting plasmid 
for creation of  a nested set of 5' deletions as shown in Fig. 1. The 5' deletions 
were created by partial or complete digestion of cTNT-3,000 at Pst I, Bgl 
II, Pvu II, Dde I, Hae III, and Sma I sites located at nuclcotide positions 
-1,100, -550, -268,  -201, -129, and -49, respectively. Restriction sites 
leaving overhanging ends were filled in with reverse transcriptase or di- 
gested with S-1 nuclease, and Hind III linkers added. After digestion with 
Hind III the fragments were gel isolated and cloned into the Hind III site 
of pBR-CAT.  The structure of each plasmid was confirmed by restriction 
endonnclease mapping or nucleotide sequencing, or both. These plasmids, 
designated cTNT-I,100,  -550,  -268,  -201,  -129,  -49, respectively, there- 
fore share a common 3' end with cTNT-3,000,  but have varying amounts 
of upstream DNA deleted as indicated in Fig. 1. Since each deletion mutant 
was inserted into the same position of  pBR-CAT, the upstream plasmid DNA 
sequences were identical for all constructions. To remove the cTNT TATA 
box  and  transcription  initiation  site,  cTNT-129  and  cTNT-268  were 
digested with Sma I, which cleaves at nucleotide position -49 and at a poly- 
linker site downstream of position +38, and recircularized with T4 ligase. 
These clones are designated as cTNT-129[A-49/+38]  and cTNT-268- 
[A-49/+38]  (see Fig.  1 b). 
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to -550 was isolated from cTNT-I,100 by simultaneous digestion with Pvu 
II and Bgl II. Hind III linkers were ligated to both ends after filling in the 
Bgl II site with reverse transcriptase. The fragment was cloned into the Hind 
III site of the pUC-based enhancer test plasmids pTE-2AS/N or pTE-2 
which places the cTNT fragment either directly in front of the HSV tk pro- 
moter or at a position 600-bp upstream of  the tk promoter, respectively (15). 
Orientation of the cTNT fragment with respect to the tk promoter was ascer- 
tained by restriction mapping. 
bACT-275-CAT. The promoter region of the chicken beta-actin gene (41) 
was isolated by partial digestion with Hpa II at position +61 within the first, 
untranslated exon, followed by complete cleavage at an Xho I site located 
at position -275. After addition of Hind III linkers as described above, the 
promoter fragment was gel isolated and inserted into the Hind III site of 
pBR-CAT. The structure of  the fusion between beta-actin exon I and the CAT 
gene  was confirmed by  DNA  sequencing and  restriction endonuclease 
mapping. 
Preparation of Cultured Cells 
Embryonic Skeletal Muscle Cultures. Chicken day 11 embryo breast mus- 
cle tissue was dissected free of  skin and cartilage and then dissociated either 
by mechanical means (8, 39), or by trypsinization (1), and then plated on 
gelatinized tissue culture plates at 1.5 ×  106 cells per 100-ram Corning tis- 
sue culture plate (American Scientific Products, McGaw Park, IL). Inclu- 
sion of 0.05%  trypsin in 0.02%  EDTA standard trypsin versene (STV) in 
the dissociation step did not affect the results presented here. The medium, 
consisting of Dulbecco's minimal essential medium (DME) supplemented 
with 10% horse serum (heat inactivated), 2.5% chicken embryo extract and 
100 U/ml each of penicillin and streptomyocin was changed the day after 
plating, 3 h before initiation of transfection. 
Embryonic Heart Cell Cultures.  Heart cell cultures were prepared by 
methods modified from established procedures (13, 14, 38, 59, 64). Briefly, 
hearts were excised from day 6 chicken embryos, dissected free of peri- 
cardia and great vessels under sterile conditions and then minced into small 
fragments. After rinsing in clean PBS, the tissue fragments were incubated 
in 10 mi of STV for 10 rain at room temperature with gentle mixing. The 
supernatant from this was discarded and 7 ml fresh STV added. After an 
additional 8 min of digestion, the supernatant was transferred into a 50-ml 
Falcon tube containing 10 ml of ice-cold nutrient medium (5 % fetal bovine 
serum,  100  U/ml of penicillin and  streptomycin in  M199  medium with 
Earle's balanced salt solution [EBSS]). The remaining tissue was redigested 
as above for 3 to 4 additional cycles and the supernatants pooled. Liberated 
cardiac cells were collected by centrifugation at 2,000 rpm for 10 min at 
4°C, resuspended in nutrient medium, and passed through a 20-ttm mesh 
nylon screen to remove aggregates. Dissociated heart cells were plated at 
a density of 2.5  ×  106 cells per 60-mm tissue culture plate. For histologi- 
cal studies, cells were cultured on rat tail collagen-coated aclar coverslips 
in 35-mm tissue culture plates. Cells were maintained in a 37°C humidified 
incubator with a 5% CO2 atmosphere. Medium was changed the day after 
plating, 3 h before initiating transfections. 
Chicken Embryo bibroblast Cultures.  Fibroblast cells were prepared 
from day 11 chicken embryos from which the head, viscera and appendages 
had been removed (58). After  dissociation with STV, fibroblasts were grown 
in M199  medium supplemented with 10%  tryptose phosphate,  10%  FCS 
and 2% chicken serum. Primary fibroblast cultures were initially plated at 
1.5  x  106 cells per 100-mm culture plate and were passaged at least three 
times (1:3 split) to remove myogenic cells before being used in transfection 
experiments. For transfection experiments, fibrohlast cells were plated at 
1.5  ×  106 cells per 100-mm culture plate and the medium changed the day 
after plating, 3 h before transfection. 
Immunofluorescence Microscopy 
The properties of the mouse monoclonal antibody prepared against bacterial 
CAT have been described (25). This antibody is highly specific for bacterial 
CAT and does not cross react with vertebrate cellular proteins. The rabbit 
antisera prepared against desmin binds to intermediate filaments in skeletal, 
cardiac, and smooth muscle but not to the vimentin intermediate filaments 
in fibroblasts (6,  17). 
For double-label immunofluorescence analysis of transfected cells, cul- 
tures were rinsed with PBS and fixed for 5 min at room temperature in 4% 
formaldehyde in PBS. The cells were then rinsed twice briefly with PBS and 
coverslips placed in ice cold methanol for 4 rain followed with ice-cold ace- 
tone for 2 min. Cells were then immediately rehydrated in PBS and washed 
three times for a total of 15 min with PBS. To stain cells simultaneously 
with the rabbit polyclonal anti-desmin (gift of H. Holtzer, University of 
Pennsylvania [Philadelphia, PA] and ICN Nutritional Biochemicals, Cleve- 
land, OH) and mouse monoclonal anti-CAT (gift ofC. Gorman, Genentech 
Corp., South San Francisco, CA), coverslips were incubated simultaneously 
with the appropriate dilution of each antibody in a humid chamber at 37°C 
for I h, washed three times for a total of 30 rain with PBS, and subsequently 
incubated with a 1:200 dilution each of rhodamine-labeled goat anti-mouse 
IgG and fluorescein-labeled goat anti-rabbit IgG (Cappell  Laboratories, 
Cochranville, PA) in a humid chamber at 37"C for 1 h. For some experi- 
ments, after primary antibody incubation and washing, CAT antibody was 
visualized by incubating cells with a  1:200 dilution of biotinylated horse 
anti-mouse IgG (Amersham Corp.) for 1 h at 37°C, followed by a  1:200 
dilution of Texas Red-conjugated streptavidin (Amersham Corp.) at room 
temperature for 30 min. Cells were then washed three times for a total of 
30 min with PBS, dehydrated in a graded ethanol series and mounted in 
Mowiol.  In  some  preparations,  the  DNA  binding  fluorochrome  DAPI 
(Sigma Chemical Co., St. Louis, MO) was used to visualize nuclei. Cells 
were examined with either a Leitz or a Zeiss epifluorescence microscope 
using the appropriate filters to selectively visualize fluorescein, rhodamine 
or Texas Red fluorescence. 
Purity of the muscle cultures was monitored irnmunochemically to estab- 
lish the fraction of  muscle and nonmuscle  cells at various times after plating. 
For skeletal muscle cells, 75 to 90% of the nuclei in skeletal muscle cultures 
resided in desmin-pesitive cytoplasm even after 72 h in culture. Heart cell 
cultures are 70-80%  cardiac myocytes 24 h after plating; however, after 
72 h in culture, the proportion of cardiac myocytes dropped to 50-60%. 
Based on incorporation of [3H]thymidine,  this shift was apparently due to 
the lower mitotic rate of  myocardial cells than nonmyocardial cells in culture 
because, over a 48 h period, only 17% of myocardial cells showed nuclear 
incorporation of [3H]thymidine,  as compared with 66% for nonmyocardial 
cells. 
Cell Transfection 
Twenty-four h after cell plating the medium was changed and 3 h later the 
cells were transfected with  DNA-calcium phosphate precipitates as de- 
scribed by Graham and van der Eb (27) and Gorman, Moflit and Howard 
(25) using 10 lag of  plasmid DNA which has been purified by banding twice 
on cesium chloride-ethidium bromide density gradients. After 4 h at 37°C, 
the  medium  containing  the  DNA  precipitate  was  removed;  cells  were 
washed with 10 ml of serum-free medium and then treated with 1 ml of 15 % 
glycerol  in  a  Hepes  (N-2-hydroxylpiperazin-N'-2-ethanesulfonic acid)- 
buffered sodium phosphate solution for 10 s (muscle cells) or 30 s (fibroblast 
cells) at room temperature (25). The glycerol solution was removed and the 
cells were washed with 10 ml of serum-free medium and then incubated with 
10 ml of complete medium at 37°C for 48 h.  Transfection of DNA into 
cardiac cell cultures was carried out as described above except that the trans- 
fection cocktail/medium mixture was left on the cells for 6 h, after which 
it was removed and the cells rinsed once with fresh nutrient medium and 
then glycerol shocked for 30 s. 
Several  measures were taken  to ensure that  CAT  activity differences 
among promoters are not due to transfection variability.  First, all compari- 
sons are based on data collated from at least six separate experiments, except 
in a few cases where noted. Second, all constructions to be compared were 
transfected simultaneously in each experiment onto duplicate or triplicate 
plates. The values observed were reproducible from experiment to experi- 
ment. Third, the same DNA-calcium phosphate transfection cocktail was 
applied both to muscle and fibroblast cultures within each experiment. 
Fourth, different preparations of each plasmid construction were used in 
parallel experiments. These last two measures were taken to rule out either 
transfection cocktail or plasmid DNA preparation as potential sources of  the 
differences observed. Using these procedures, the SEM, in most cases, is 
less than 10% of the observed signal. Experiments using co-transfection of 
a second control plasmid (63) showed competitive interference between the 
control promoters and the cTNT promoters. This was due to a property in- 
herent in the cTNT promoter because co-transfection of RSV-I~-galactosi- 
dase (63) did not interfere with expression of the HSV tk promoter in the 
cell systems reported here. In experiments using the RSV-I~-galactosidase 
as the control plasmid, the mean corrected level of CAT activity directed 
by the HSV tk promoter and the SEM were essentially identical to that ob- 
tained when the above precautions were taken. Both methods gave activity 
values with SEM of less than  10%  indicating that both procedures gave 
equivalent results. 
The  activity differences among constructions were also analyzed by 
statistical methods. The data were subjected to a two-way analysis of vari- 
ance, or an analysis of variance for repeated samples, using Crunch statisti- 
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CAT activity  values  determined for any two constructions  were statistically 
different.  Promoter  activities  were  considered different only  when the 
confidence level  is within P  =  0.01-0.05. 
CAT Assay 
Cell extracts were prepared by sonication and centrifugation (25) and CAT 
activity was assayed using [J4C]chloramphenicol (25, 63). The amount of 
extract employed was varied to ensure that CAT  activity was measured 
within the linear range. The linearity of the CAT assay reaction was deter- 
mined empirically. Reaction products were separated by ascending chroma- 
tography on silica gel plates using chloroform-methanol (90:10 vol/vol). Af- 
ter autoradiography, acetylated and unreacted [~4C]chloramphenicol  were 
quantified by liquid scintillation counting. 
Results 
Construction of  cTNT-CAT Fusion Genes 
The overall structure of the chicken cTNT gene, as shown in 
Fig.  I  a,  was determined by nucleotide sequencing of the 
cloned  gene  (12).  The  promoter/upstream  region  of the 
cloned cTNT gene was isolated by partial digestion at an Ava 
II restriction endonuclease cleavage site located 38 nucleo- 
tides into exon 1, and an artificial Eco RI site located 3 Kb 
upstream (Fig. 1 b). This cTNT promoter/upstream segment 
was then cloned into the Hind III site of pBR-CAT (Fig.  1 
c). This construction (cTNT-3,000) fuses the cTNT untrans- 
lated first exon to the untranslated region of the CAT gene, 
and places the transcription of the CAT gene under control 
of  the  cTNT  promoter  and  transcription  initiation  site. 
Progressive deletions from the 5' end of cTNT- 3,000 were 
made by partial or complete digestion at convenient restric- 
tion endonuclease cleavage sites (Fig.  1 b).  Each deletion 
segment was then cloned into the Hind III site located up- 
stream  of the  CAT  gene  in  pBR-CAT  (see  Fig.  1  c  and 
Materials and Methods).  This created a nested set of cTNT 
promoter/upstream deletion mutants which had identical 3' 
endpoints  in  exon  1  and  identical  5' flanking  vector  se- 
quences,  but  which  lacked  varying  amounts  of upstream 
DNA as diagrammed in Fig.  1 b. 
Transfection of  cTNT-CAT Fusion Genes into 
Embryonic Skeletal Muscle Cultures 
Mononucleated  myoblasts  from day  11  chicken  embryos 
were plated at  1.5  ×  106 cells per  100-mm plate and cul- 
tured using standard procedures. After ,,o48 h in culture, the 
mononucleated myoblasts fuse to form differentiated, mul- 
tinucleated myotubes. For transfection experiments,  a  cal- 
cium phosphate precipitate containing  10 pg plasmid DNA 
was introduced  into cultures  24 h  after plating,  when the 
level of myocyte differentiation is very low. 48 h after trans- 
fection,  the  well-dlfferentiated  muscle  cultures  were  har- 
vested  for determination  of the  level of CAT expression. 
Thus,  the  greatest proportion  of cells  taking  up  plasmid 
DNA at the time of transfection were undifferentiated myo- 
blasts, but by the time of harvest, the majority of these trans- 
fected cells had differentiated. Therefore, the CAT activity 
detected was attributable to expression within differentiated 
myotubes. This conclusion is further supported by inununo- 
cytochemical analyses described below. 
Each of the cTNT deletion mutants shown in Fig.  1 b was 
transfected into embryonic skeletal muscle cultures and the 
resulting CAT activity determined. Table I shows the collated 
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Figure 1.  Construction  of expression  constructs  containing  the 
chicken cTNT promoter/upstream region and the chicken beta-actin 
promoter region linked to the CAT coding sequence. (a) The struc- 
ture of the 9.2-kb chicken cTNT gene. Closed boxes represent the 
18 exons of the cTNT gene; thin lines represent intron and flanking 
sequences.  (b) The cTNT promoter/upstream  region.  Upper por- 
tion is an expanded representation of the 3-kb upstream segment 
of  the 6I'NT gene shown in (a). T and C represent the putative TATA 
and CAAT homologies; 5' ut, 5' untranslated region of the cTNT 
gene; (PL) polylinker region; arrow indicates the transcription initi- 
ation site. The Ava II site was destroyed in the process of cloning. 
Lower portion  shows the cTNT promoter/upstream  deletion seg- 
ments generated by digestion of the 3-kb segment at the restriction 
enzymes sites shown. These segments were cloned into pBR-CAT 
as described in the text. (c) Structure of pBR-CAT (63). (Shaded 
box) coding  sequence of the  CAT gene with arrow showing the 
direction of  transcription and the AUG codon is indicated; (hatched 
box) SV-40 splice signal and polyadenylation sequence. Test pro- 
moter segments  were  cloned  into  the  Hind  III site. Thin  line 
represents pBR322 sequence; ori in open box, origin of replication 
of pBR322; AmlY, ampicillin resistance gene with arrow showing 
the direction of transcription.  (d) I~ACT-275. The beta-actin pro- 
moter segment  was excised from the  beta-actin  gene by partial 
digestion with Hpa II and by complete digestion with Xho I and 
cloned into pBR-CAT as described in the text. Both the Xho I and 
Hpa II sites were destroyed in the cloning step. C, T, and PL indicate 
CAAT and TATA  homologies and polylinker region, respectively. 
data from at least six independent experiments for each dele- 
tion mutant. Multiple experiments using triplicate samples 
and at least two different DNA preparations were used to 
control for transfection efficiency.  Co-transfection of control 
markers with the cTNT-CAT constructions resulted in com- 
petition between the cTNT test promoter and control pro- 
moters. To ensure consistency between experiments, all the 
constructions  were transfected simultaneously and control 
constructions  (pBR-CAT,  RSV-CAT and  I~ACT-275-CAT) 
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CAT activity  in 
Skeletal  Cardiac  Fibroblast 
Promoter  myocytes  myocytes  cells 
U  ×  10  -2  U  X  10-  2  U  X  10  -2 
cTNT-3000  15.0  +  3.0  1.04  +  0.28  0.28  +  0.02 
cTNT-II00  46.0  +  6.0  1.49  +  0.51  0.31  +  0.03 
cTNT-550  90.0  +  7.0  4.07  +  1.04  0.18  +  0.02 
cTNT-268  17.0  +  2.0  1.41  +  0.16  0.30  +  0.03 
cTNT-201  15.0  +  3.0  0.24  +  0.11  0.33  +  0.03 
cTNT-129  26.0  +  3.0  0.17  +  0.08  0.36  +  0.04 
cTNT-49  0.16  +  0.05  0.14  +  0.03  0.14  +  0.05 
cTNT-129[A-49/+38]  0.16  +  0.05  0.09  +  0.06  0.07  +  0.03 
cTNT-2681A-49/+38]  0.13  +  0.05  0.16  +  0.04  0.11  +  0.02 
13ACT-275  90.0  +  4.0  6.6  +  0.98*  139  5-  14 
RSV LTR  305  5-  108  20.9  5-  4.3*  693  +  39 
The CAT activity values shown are the average of a minimum of six determina- 
tions,  except for that of cTNT-49, and cTNT-129[A-49/+38] for which 
only three determinations were made. The SEM is given in each case. The ac- 
tivity of pBR-CAT (0.44  +  0.13;  0.28  +  0.08  and 0.24  +  0.04  for skeletal 
myocytes, cardiac myocytes and fibroblast cells,  respectively) was subtracted 
from each value indicated. 
* As described  in the text,  the values shown for the beta actin (13ACT-275) 
and RSV-LTR promoters  in cardiac myocytes have been corrected  to account 
for the fractional contribution of CAT activity derived from cardiac myocytes 
to the overall activity in these samples, determined as in Table I1. The uncor- 
rected values for the beta-actin and RSV-LTR promoters in heart cell cultures 
were 49.6  ±  7.4  and  158  +  33,  respectively. 
cTNT-268  oTNT-201 
]  I 
CTGGCTGGC'TrGTGTCAGCCCTCGGGGACTCACGTATCTCC~GIAC, GGIGTITAAAATAGC/IAA/LC  TCTGAUGGCAC 
I  I 
-260  -200 
oTNT-129 
I 
AGAATAGCr  r  GGIGCTrATATGI(~GC  Tc~rI~I'~  ~T 
I 
-1$0 
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I 
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Figure 2. Nucleotide sequence of  the 5' flanking region of  the cTNT 
gene. The nucleotide sequence of the 5' flanking 268 nucleotides 
and the first 38 transcribed nucleotides of  the eTNT gene was deter- 
mined as described elsewhere (12). The endpoints of several dele- 
tion mutants used in these studies are shown. The position of  a puta- 
tive CCAAT, SP-I and TATA homologies are indicated by thin, 
thick and open bar underlining, respectively. Two copies of a con- 
served heptamer (53) are shown by double underlining. The signa- 
ture double initiation site for the cTNT gene in embryonic skeletal 
and cardiac muscle (12) is shown by the double arrows. 
were included in every experiment (for details, see Materials 
and Methods). 
One of the primary goals of these experiments was to de- 
termine the minimum amount of  upstream DNA required for 
activity of the cTNT promoter in embryonic skeletal muscle 
cells. Table I shows that cTNT- 129 directs a high level of 
CAT expression in embryonic skeletal muscle cells, cTNT 
-129  contains many of sequence motifs expected for eu- 
karyotic  promoters,  including  putative  TATA,  SP-1, and 
CCAAT homologies, 38 nucleotides of exon 1, as well as two 
copies of the heptamer CATTCCT which is found in many 
contractile protein gene promoter regions (see Fig.  2, and 
references 12 and 53). Deletion to position -49 (cTNT-49; 
Fig.  1), leaving only the proximal segment containing the 
putative TATA motif and exon 1 sequence (Fig. 2), reduces 
CAT activity to a basal level comparable to pBR-CAT which 
lacks a eukaryotic promoter (Table I). Similarly, the cTNT 
promoter is inactive in the absence of the proximal segment, 
between positions -49 and +38 (Table I). These internal de- 
letion experiments indicate that both the proximal and distal 
segments of cTNT- 129 appear to be required for activity in 
skeletal muscle cells. 
In addition to defining an approximate minimum promoter 
region, the results with the nested set of upstream deletions 
indicate that the presence of regions upstream of the  -129 
position can affect the overall level of activity of the cTNT 
minimum promoter. Inclusion of the region between posi- 
tions  -268 and  -129 (cTNT-201, and cTNT-268, Table 
I) has little effect upon activity. However, additional inclu- 
sion of the -550 to -269 segment results in a threefold in- 
crease in the level of CAT expression (cTNT-550, Table I). 
Inclusion of additional  upstream  DNA  (cTNT-1,100 and 
cTNT-3,000i Table I) results in diminution of the level of 
CAT expression. These effects of upstream regions could be 
due to the presence of positive and negative regulatory ele- 
ments or to effects of spacing between the cTNT promoter 
and plasmid vector sequences. 
To determine if the apparent positive effect of the  -550/ 
-269  region  could  act  independent  of surrounding  se- 
quences, we tested its ability to affect CAT expression under 
the control of a  heterologous promoter.  For these experi- 
ments we used a series of pUC-based plasmids designed for 
testing potential enhancer-containing DNA segments. Test se- 
quences may be inserted into a polylinker located either at 
a distal site 600 nucleotides upstream (pTE-2), or a prox- 
imal site immediately upstream (pTE-2AS/N) of  the Herpes 
simplex  virus  thymidine kinase  (HSV  tk)  gene promoter 
(15).  The level of CAT activity expressed under control of 
the HSV tk promoter in the plasmids carrying a test segment 
was  then compared with  that of the parent plasmid.  The 
-550/-269 segment was excised and cloned into these two 
plasmids via linkers in both orientations (Fig. 3 a). Fig. 3 
b  shows that the presence of the  -550/-269  segment in- 
creased expression of CAT under control of the HSV tk pro- 
moter approximately two- to threefold in skeletal muscle cul- 
tures, in an orientation- and position-independent manner. 
Little or no potentiation was observed after transfection into 
fibroblast cultures (Fig. 3 b). Unlike the cTNT promoter, the 
HSV tk promoter was found to be minimally affected by the 
presence ofa co-transfection marker. Using RSV-13-galactos- 
idase as a co-transfected marker to control for transfection 
efficiency the  preferential potentiation of CAT activity in 
muscle cells transfected with test plasmids  containing the 
-550/-269 segment was also evident (Fig. 3 c). Thus, the 
level of potentiation of CAT expression from the HSV tk pro- 
moter by the -550/-269 segment is similar to that observed 
when it is  present in  its  normal position upstream of the 
cTNT promoter. 
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Figure 3. Test of ability of -550/-269 segment to enhance expres- 
sion from a heterologous promoter. (a) The cTNT-550/-269 seg- 
ment was inserted into a polylinker (PL) in either a proximal or dis- 
tal  position  upstream  of the  HSV  tk  promoter  in  the  plasmids 
pTE-2AS/N or pTE-2, respectively (15). Recombinant plasmids 
with the insert in either a positive or negative orientation (indicated 
by arrows) relative to its normal position in the drNT gene were 
selected and transfected into skeletal muscle and fibroblast cultures. 
(b) The average CAT activity and SEM  of each parental tk-CAT 
plasmid without an insert (designated none), and tk-CAT containing 
the  -550/-269  segment in the  positive (pos) or negative (neg) 
orientation is shown. The number of independent determinations 
(n) for each experiment is shown above the corresponding bar. For 
details see Materials and Methods.  (Black bars) CAT activity in 
skeletal muscle cells; (striped bars) CAT activity in chicken embryo 
fibroblasts. (c) As in b except that CAT activity was normalized to 
co-transfected RSV-I~-galactosidase.  Values are derived from dupli- 
cate samples. 
Transcriptional Strength of the cTNT Promoter 
in Skeletal Muscle Cells 
The transcriptional strength of the cTNT promoter/upstream 
segments in skeletal muscle cells was estimated by compar- 
ing CAT activity governed by each of them with that directed 
by two control promoters,  those of the Rous sarcoma virus 
long terminal  repeat (RSV-LTR) and the chicken beta-actin 
gene (I~ACT-275, see Fig.  1 d). Both of these promoters are 
strong chicken promoters which are active in a wide variety 
of cell types (19, 24). The construction of RSV-CAT has been 
described (24).  The 13ACT-275  plasmid contains the DNA 
segment between  -275 and  +40 relative to the site of tran- 
scription  initiation  in the chicken beta-actin gene  (see Fig. 
1 d).  Although  the  endogenous  beta-actin  gene  is  down- 
regulated in differentiated muscle cells in vivo, we found the 
activity of 13ACT-275-CAT was similar in transfected skele- 
tal  muscle  and  fibroblast  cells  (Table I).  Thus,  the  cis  se- 
quences required for beta-actin gene down regulation do not 
appear to be present (or active) on the segment we have iso- 
lated,  so  I~ACT-275-CAT  serves as a  good cell  type non- 
specific control promoter in these experiments.  The level of 
CAT expression under control of the I~ACT-275 was equiva- 
lent to that under control of cTNT-550,  the strongest cTNT 
promoter/upstream segment (Table I). Both of these cellular 
promoters  were  ,,otA as  active  as  the  RSV-LTR  (Table  I). 
Figure 4.  Primer extension analysis of CAT mRNA in transfected 
chick primary skeletal  muscle cells. (a) Diagrammatic representa- 
tion of the structure of the initiation site regions of RSV-CAT and 
cTNT-550-CAT. (Short open bar) 5' flanking DNA; (tall open bar) 
polylinker DNA; (long black bar) exon 1 sequence; (long stippled 
bar) CAT gene sequence. Thick and thin portions of vertical arrow 
represent  oligonucleotide  primer  and  extended  cDNA,  respec- 
tively. Arrowheads indicate the position of the single expected initi- 
ation site for RSV-CAT and the signature double initiation sites of 
the cTNT gene.  (b) Autoradiograph of 6%  sequence gel showing 
primer extension run-offproducts. Horizontal arrowheads show the 
position of the run-off products for 10 gg total  RNA from; (RSY) 
cultures transfected with RSV-CAT at 109 nucleotides; and (cTNT) 
the double run-off bands at  145 and  141  nucleotides for cultures 
transfected with cTNT-550-CAT. Nonspecific terminations below 
100 nucleotides were present in both samples but are more visible 
in the cTNT lane because it was exposed five times longer than the 
RSV lane. Only the full-length run-off products indicated by the ar- 
rows were scanned for quantitation.  Size markers are derived from 
a  Hpa II digest of pBR-322 endlabeled with [32P]dCTP using re- 
verse transcriptase. 
Since the RSV-LTR is one of the strongest known viral pro- 
moters (24, 63) and is stronger than any known cellular pro- 
moter,  we conclude  that both  cTNT-550  and  13ACT-275 
are strong cellular promoters  in  skeletal  muscle cells. 
The  site  of transcription  initiation  from  the  transfected 
cTNT and RSV promoters was determined by primer exten- 
sion  using  an  oligonucleotide  primer  complementary  to 
codons 6-11 of CAT mRNA (63).  RNA from cultures trans- 
fected with RSV-CAT gave a primer extension run-off length 
of  109  nucleotides  indicating  that  CAT  mRNAs  governed 
by the RSV promoter were initiated at the expected site (Fig. 
4; reference 63).  RNA from cultures transfected with cTNT 
-550-CAT yielded two predominant run-off lengths of 141 
and  145  nucleotides  (Fig.  4),  indicating  that  initiation  oc- 
curred at the first and fifth nucleotides of cTNT exon  1. This 
double  initiation  signature  is  characteristic  of cTNT  tran- 
scription initiation (see Fig. 2 and reference 12) and indicates 
that transcription initiation from the transfected gene mimics 
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initiated CAT mRNA under control of the cTNT and RSV 
promoters was estimated by densitometry scanning of the 
films to be 0.2, in good agreement with the relative level of 
CAT activity of 0.3 specified by the two promoters (Table I). 
Transfection  of  cTNT-CAT Fusion Genes into 
Embryonic Heart Cell Cultures 
Heart cell cultures were established using cells dissociated 
from day 6 and day 10 embryo hearts. Cultures from day 6 
embryo hearts were chosen for the experiments reported be- 
low because they were found to be more easily transfected 
than those from day 10 embryos. Results with heart cell cul- 
tures from either age embryo were, however,  qualitatively 
identical. The optimum schedule for transfection of myocar- 
dial cultures was found to be the same as that for skeletal 
muscle cultures; i.e., cells were transfected 24 h after plating 
and harvested for CAT activity 48 h later.  Myocardial cell 
cultures were less homogeneous, in terms of the proportion 
of myogenic cells, than skeletal muscle cultures. Immunocy- 
tochemical analysis showed that ~80% of the nuclei resided 
in cytoplasm binding antibody against the muscle specific in- 
termediate filament protein desmin after 24  h  in culture. 
However, after 72  h  in culture the proportion of desmin- 
positive cells had decreased to 50-60%. This change was at- 
tributable to a higher rate of cell division for nonmyocardial 
cells as demonstrated by a fourfold higher rate of thymidine 
incorporation (see Materials and Methods). 
The  transfection efficiency of myocardial and  nonmyo- 
cardial cell types within embryonic heart cell cultures was 
also found to differ. Using a monoclonal antibody for CAT 
protein (23), transfected cells could be detected immunocy- 
tochemically. Table II shows that in heart cell cultures trans- 
fected with RSV-CAT,  an average of 6.5  times more non- 
myocardial (desmin-negative) cells were CAT-positive than 
myocardial cells (desmin-positive). Thus, the overall trans- 
fection efficiency of myocardial cells is much lower than that 
of nonmyocardial cells. These immunofluorescence data in- 
dicate, as a first approximation, that of the total CAT activity 
directed by the RSV-LTR or beta-actin promoters measured 
in transfected heart cell cultures, only 1 part in 7.5 is at- 
tributable to activity in myocardial cells (see legend to Table 
I).  The lower levels  of CAT activity for heart cultures vs. 
skeletal muscle cultures (Table I), therefore, reflect the lower 
percentages of myogenic cells transfected in heart cultures. 
Skeletal muscle and fibroblast cultures were transfected with 
similar efficiency (~2%, data not shown). 
Table  I  shows the CAT activity levels specified by each 
member of the set of cTNT deletions after transfection into 
heart cell cultures. These results indicate that the shortest de- 
letion mutant which is active in cardiac cells contains 268 
upstream nucleotides (see Fig. 2 for nucleotide sequence). 
Deletion to position -201 essentially abolishes CAT activity 
under control of the cTNT promoter, reducing it to a level 
comparable  to  the  promoterless  pBR-CAT  (see  Table  I). 
Similarly, cTNT- 129, which was strongly active in skeletal 
muscle cells, is also inactive in cardiac cells. Thus, the up- 
stream segment between positions -268 and -201  appears 
to be required for a significant level of cTNT promoter activ- 
ity in cardiac cells. 
The region between -550 and -269, while not required 
for activity, also increases the level of CAT expression under 
Table II. Immunocytochemical Analysis of Transfection 
EJficiency in Heart Cell Cultures 
Number of CAT-positive cells staining 
Experiment  no.  Desmin-positive  Desmin-negative  Ratio 
1  28  202  11.3 
2  36  121  4.3 
3  80  337  4.6 
Av.  6.5 
Heart cell cultures established on aclar coverslips in 35-ram dishes were trans- 
fected 24 h after plating,  essentially as described  in Materials and Methods. 
48 h  after  transfection,  the  cells  were processed  for immunocytocbemistry 
as described in Materials and Methods. Every CAT-positive cell on a 22 rnm-' 
aclar  coverslip  was determined and assayed  for staining with  anti-desmin. 
The percentage of desmin-positive cells was then determined for each experi- 
ment to allow normalization  of the relative number of myocardial  and non- 
myocardial cells  for determination of relative transfection efficiency (Ratio). 
The fraction of desmin-positive cells was 0.61,  0.56 and 0.52 for experiments 
1,2, and 3, respectively. Each transfection experiment was conducted indepen- 
dently by a separate operator and the immunocytochemical counting performed 
by a fourth operator. 
control of the cTNT promoter in cardiac cells by approxi- 
mately threefold, in a manner similar to its effect in skeletal 
muscle cells. In addition, the regions upstream of position 
-550 appear to suppress the maximal activity of the cTNT 
promoter similar to the effect of this region in skeletal muscle 
cells. Therefore, the effects of  upstream regions upon activity 
of the minimum cTNT promoter in both cardiac and skeletal 
muscle appear to be similar. 
The  transcriptional  strength  of the  cTNT  promoter  in 
cardiac myocytes was also evaluated by comparison to that 
of the  RSV-LTR  and  beta-actin  promoters.  As  indicated 
above, the beta-actin and RSV-LTR promoters are preferen- 
tially expressed in nonmyocardial cells owing to a difference 
in transfection efficiency. Since the cTNT promoter was only 
expressed  in  myocardial cells  (see  below),  the measured 
level of CAT activity directed by each of the cTNT construc- 
tions was directly comparable to that of the corrected values 
of the beta-actin and RSV-LTR promoters as shown in Table 
I. Using this comparison, the activity of cTNT-550 is ap- 
proximately equivalent to that of the beta-actin promoter in 
cardiac muscle cells.  Thus, the relative strength of cTNT 
-550 appears to be approximately equivalent in embryonic 
cardiac and skeletal muscle cells. The low efficiency  of trans- 
fection of myocardial cells precluded using primer extension 
to determine the transcription initiation site of the transfected 
cTNT promoter. However, the site of transcription initiation 
from the endogenous cTNT gene is identical in embryonic 
cardiac and skeletal muscle cells (12) so there is no a priori 
reason to suggest that the transfected cTNT gene would use 
a  different site in cardiac muscle cultures than in skeletal 
muscle cultures. In addition, deletion of the -49 to +38 re- 
gion of cTNT-268 (which contains the putative TATA mo- 
tif, transcription initiation sites and exon 1; see Fig. 2) abol- 
ishes  activity  in  cardiac  cells  (cTNT-268[A-49/+38]; 
Table I), which is also consistent with expression being de- 
pendent upon transcriptional initiation at the natural cTNT 
sites. 
Cell-specificity  of the cTNT Promoter 
The cell specificity of the cTNT and control promoters was 
assessed by comparing the level of CAT expression in skele- 
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embryo fibroblasts were prepared and cultured under stan- 
dard conditions and passaged at least three times before use 
in transfection experiments to eliminate potentially myogenic 
cells. Fibroblast cultures were transfected 24 h after plating 
and harvested 48 h later. In most cases, the same transfection 
cocktail was  simultaneously applied to fibroblast cultures 
and to myogenic cultures. 
While both the beta-actin and RSV-LTR promoters were 
found to be highly active in fibroblast cells, the activity of 
the cTNT promoter/upstream segments was extremely low in 
these cells (Table I). The activity of the cTNT promoter/up- 
stream segments was only approximately twofold higher than 
that of pBR-CAT,  which lacks a eucaryotic transcriptional 
promoter (Table I). Thus, the cTNT promoter appears to be 
essentially  inactive  in  fibroblast  cells  regardless  of the 
amount  of upstream  DNA  present.  The  degree  of cell 
specificity of each cTNT deletion mutant was estimated by 
comparing its level of CAT expression to that of the noncell- 
specific bACT-275-CAT in each cell type (Table III). These 
results indicate that the minimum cTNT promoter in cardiac 
and  skeletal  muscle cells  is  approximately two orders  of 
magnitude more active than it is in fibroblasts (Table III). 
With addition of the -550/-269 region, the overall level of 
cell specificity increases to almost three orders of magnitude 
for both cell types. Thus, by these criteria, the cTNT pro- 
moter appears to carry cis elements directing a high degree 
of striated muscle specific transcription. 
The cell-specificity of the cTNT promoter in skeletal and 
cardiac muscle cells was also analyzed by immunocytochem- 
istry. Cardiac and skeletal muscle cultures, grown on cover- 
slips, were transfected with either RSV-CAT or cTNT-CAT 
and,  after 48 h,  were fixed and incubated simultaneously 
with anti-desmin and anti-CAT, as in Table II. Representa- 
tive micrographs from cardiac and skeletal muscle cultures 
transfected with  either cTNT-CAT or beta-actin-CAT and 
stained with anti-CAT plus anti-desmin are shown in Fig. 
5. As noted elsewhere (23), CAT staining was observed both 
within the cytoplasm and nuclei.  Desmin staining was re- 
stricted to intermediate filaments in the cytoplasm of muscle 
cells. 
The total number of CAT-positive  cells which were either 
desmin-positive (cardiac or skeletal myocytes) or desmin- 
negative (nonmyocyte) was then determined as in Table II. 
After transfection with RSV-CAT both desmin-positive and 
desmin-negative cells stained positively for CAT in Cardiac 
and  skeletal muscle cultures indicating that the RSV pro- 
moter is active in all three cell types (Table IV). The relative 
number of CAT-positive nonmyocytes is low in skeletal mus- 
cle cultures (Table IV,  :~), owing to the relative scarcity of 
these cells in these cultures (see Methods in Materials and 
Methods). The relative efficiency  of transfection of myocytes 
and nonmyocytes appears to be approximately equivalent in 
embryonic skeletal muscle cultures (see legend, Table IV, :~). 
However, in heart muscle cultures transfected with  RSV- 
CAT (Table IV, *), the proportion of CAT-positive  nonmyo- 
cytes is higher owing to the higher relative number of non- 
myocardial cells, and their higher degree of transfectability, 
in agreement with the data presented in Table II. 
When  transfected  with  cTNT-550-CAT,  on  the  other 
hand, only desmin-positive cells were observed to be CAT 
positive either in embryonic heart cell cultures or in em- 
bryonic skeletal muscle cultures (Table IV). In the thousands 
of  cells screened by this procedure, no CAT-positive/desmin- 
negative cells have ever been observed after transfection with 
cTNT-CAT. These results corroborate those based upon bio- 
chemical determination of CAT activity and indicate that the 
expression of the cTNT promoter/upstream segments tested 
here is highly specific for the same two striated muscle cells 
types to which it is restricted in vivo. 
Discussion 
In these experiments, we have used the CAT marker gene 
(24, 25) to analyze the transcriptional activity of the cTNT 
promoter/upstream region after transient transfection into 
primary  cultures  of chicken embryo cardiac  and  skeletal 
muscle cells, and fibroblast cultures. This approach has been 
used successfully in characterization of muscle actin gene 
promoters (5, 28, 51). However, no direct comparison has 
been made of the activity of one muscle promoter in both 
cardiac and skeletal muscle cells. We found that direct com- 
parisons of transcriptional activity of cTNT-CAT construc- 
tions in cardiac and skeletal muscle cells were complicated 
Table IlL Relative Activity of cTNT  Promoter Segments in Muscle and Nonmuscle Cells 
Activity relative to 13ACT-275  in 
Activity ratio* 
Skeletal  Cardiac  Fibroblast 
Promoter  myocytes  myocytes  cells  Sk/F  Ca/F 
cTNT-  3,000  0.167  0.158  0.0020  83  79 
cTNT -  1,100  0.511  0.226  0.0022  229  102 
cTNT-550  1  0.617  0.0013  772  478 
cTNT-268  0.189  0.214  0.0022  88  99 
cTNT -  201  0.167  0.036  0.0024  70  - 
cTNT-  129  0.289  0.026  0.0026  112  - 
cTNT-49  0.0018  0.021  0.0010  -  - 
cTNT-  129[A-49/+38]  0.0018  0.014  0.0005  -  - 
13ACT-275  I  1  1  1  1 
RSV-LTR  3.39  3.2  5.0  1  1 
Using the data from Table I, the activity of the beta-actin promoter in each cell type was set at unity, and the relative activities for all other constructions calculated 
relative to that. 
* The ratio of activity for each construction in skeletal myocytes vs. fibroblast cells (Sk/F) and cardiac myocytes vs. fibroblast cells (Ca/F). Ratio values are round- 
ed off to the nearest whole number,  and are omitted where only nominal activity was detected in skeletal or cardiac myocytes. 
The Journal of Cell Biology, Volume  107,  1988  580 Figure 5.  Double-label immunofluorescence micrographs of transfected  primary embryonic heart (A-D) and skeletal  (E and F) muscle 
cultures.  Cultures were transfected  and fixed as indicated  in the text, and stained simultaneously  with a rabbit polyclonal antibody against 
desmin and mouse monoclonal antibody against CAT. Binding of the desmin antibody was visualized  using fluorescein-conjugated  anti- 
rabbit IgG (A, C, and E); binding of CAT antibody was visualized  using either a rhodamine-conjugated  anti-mouse IgG (D), or using 
a biotinylated anti-mouse IgG followed by Texas Red-conjugated streptavidin (B and F). (A and B) cultured heart cells 48 h after transfection 
with [3ACT-2"/5-CAT, The same microscopic field visualizing two CAT-positive cells  (arrows in B) which are identified  as noamuscle 
cells by their failure to bind the antibody against desmin (A). Three desmin-positive  cardiac myocytes are visible in this field.  (C and/9) 
Cultured heart cells 48 h after transfection  with cTNT-268-CAT showing the same microscopic field visualizing  a small cluster of desmin- 
positive heart cells (C) of which one binds the CAT antibody (arrows in C and D). (E and F) Skeletal muscle culture 48 h after transfection 
with cTNT-550-CAT. Two of the desmin-positive  myotubes visible  in (arrows in E) also bind the CAT antibody in F. Variations  in the 
intensity  of CAT staining,  both between  myotubes and along the length  of a single  myotube,  were frequently observed. Bars,  20 Ilm. 
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Skeletal Muscle Specific Expression of the cTNT Promoter 
Cardiac muscle cells* 
Number of CAT-positive cells staining 
Promoter  Desmin-positive  Desmin-negative 
RSV  38  220 
cTNT  40  0 
a 
1.0 
Skeletal muscle cells*  ,,t~_ 
Number of CAT-positive cells staining  ,~ 
Promoter  Desmin-positive  Desmin-negative  ~  0.5 
RSV  429  33  q,~> 
cTNT  533  0  ~-- 
tab 
* Immunocytochemicai analysis of cardiac cell cultures which had been trans-  _~ 
fected  with  either  cTNT-CAT  or RSV-CAT was conducted  essentially  as  IZ 
described in Table II. The fraction of desmin-positive cells in cultures trans- 
fected with RSV-CAT and cTNT-CAT were 0.5  and 0.52,  respectively. 
* Skeletal muscle cell cultures  were transfected  24 h after  plating,  and pro- 
cessed for immunocytochemistry as described in Table II and in Materials and 
Methods. The total number of CAT-positive  cells on a 22 mr# aclar cover- 
slip was counted and each assayed for staining with anti-desmin.  Each desmin- 
positive/CAT-positive cell was counted as a single cell regardless of the num- 
ber of nuclei present on the assumption that only one transfected nucleus was 
present per myotube. At the time point chosen ,,,75-90%  of the cells in these 
cultures  stain positively with anti-desmin,  similar to control,  nontransfected 
cultures.  Since the  relative  transfection  efficiency of muscle and nonmuscle 
cells appears to be approximately equal in these cultures,  no correction for the 
relative number of desmin-positive and desmin-negative cells has been made. 
by the fact that transfected DNA enters each cell type with 
very different efficiencies. While ,,o2% of skeletal muscle 
cells were CAT-positive by immunofluorescence, the per- 
centage of CAT-positive myocardial cells was an order of 
magnitude lower (compare to Table IV).  To calibrate the 
strength of each cTNT promoter/upstream segment in each 
cell type, therefore, we have compared the level of CAT ac- 
tivity under their control with that directed by the promoters 
of the chicken beta-actin gene and the RSV-LTR, which are 
strong  cellular  and  viral  promoters,  respectively.  In  our 
hands, neither of these standard promoters showed any ap- 
preciable degree of cell specificity, as evidenced by the fact 
that they are highly active in all cell types tested and that their 
activity relative to each other remained relatively constant in 
the cell types tested (Tables I and III). The most active cTNT 
upstream segment in both cardiac and skeletal muscle cells 
(cTNT-550) directed levels of CAT activity equivalent to 
that directed by the beta-actin promoter, indicating that the 
cTNT promoter is a relatively strong promoter in cardiac and 
skeletal muscle cells. Moreover, the similarity in maximal 
activity of cTNT-550 in both cardiac and skeletal muscle 
cells served as a means for comparing the effects of other de- 
letions in the two cell types. Fig. 6 summarized the data from 
Table I by comparing the relative activity of each upstream 
region of the cTNT gene in the two cell types. Our results 
show that while different minimum promoter/upstream re- 
gions are required for efficient activity in each cell type, 
other nonessential upstream  regions may act in  a  similar 
manner in both cell types to modify the activity of those 
minimum regions. 
The Minimum Regions Required for Expression 
of the cTNT Promoter in Cardiac and Skeletal 
Muscle Cells 
Embryonic cardiac and skeletal muscles differ in the mini- 
Cardiac 
Skeletal 
3000  1100  sso  26a  201 
///  \ 
Cardiac 
Skeletal  "1"  "!-  "1" 
Figure 6  Relative activity of the cTNT promoter segments in em- 
bryonic chicken cardiac and skeletal muscle cells. (a) The CAT ac- 
tivity value for each cTNT promoter segment shown in Table I have 
been normalized to that of cTNT-550 in each cell type. The value 
of cTNT-49 (see Table I), which is not active in either cell type, 
has been subtracted  from the CAT activity value of each active 
cTNT promoter segment. (Solid bars) Relative CAT activity value 
in cardiac cells; (stippled bars) CAT activity value in skeletal mus- 
cle cells. (b) Diagram of the minimal c'I'NT promoter segments re- 
quired for efficient transcription activity. Region which enhances 
the activity of the minimal promoter is shown with + + +; (hatched 
area) regions which had a negative effect on cTNT promoter activ- 
ity in these experiments; arrow indicates transcription  initiation 
site. Solid and stippled blocks indicate minimum regions required 
for expression in cardiac and skeletal muscle cells, respectively. 
The segment between -3,000 and -550 is not drawn to scale with 
that downstream of -550. 
mum 5' flanking regions required for cTNT gene expression. 
The minimum active segment in cardiac cells contains 268 
upstream nucleotides (Fig. 6, a  and b). The activity of the 
-268 segment is ~ % that of the most active segment which 
contains 550 upstream nucleotides (see Fig. 6 a, and below). 
Deletion of 67 nucleotides, to position -201, abolishes ac- 
tivity (Fig. 6 a, and Table I), to a level comparable to pBR- 
CAT which lacks a eucaryotic promoter (63). This indicates 
that, as a minimum, the 67 nucleotide segment between posi- 
tions  -268 and  -201 contains DNA sequences which are 
required for efficient expression of the cTNT promoter in 
embryonic cardiac cells. Obviously, sequences downstream 
of the -201 position may also be required (for example, see 
cTNT-268[A-49/+38],  Table I), but these are not suffi- 
cient for expression in cardiac cells in the absence of the 
-268 to  -201  segment. 
In embryonic skeletal muscle cells, on the other hand, a 
segment containing only  129  nucleotides upstream of the 
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mately one-third of maximal expression (Fig. 5, a  and b). 
Deletion to position -49 abolishes activity, reducing it to a 
level comparable to that of pBR-CAT  (Table I). This indi- 
cates that sequences within the segment between positions 
-129 and -49 are required for efficient expression in skele- 
tal  muscle  cells.  Addition  of  the  segment  required  for 
efficient cardiac expression (up to  -268) has a neutral, or 
slightly negative, effect upon cTNT promoter expression in 
embryonic skeletal muscle cells.  We conclude,  therefore, 
that the minimum required segments for efficient expression 
of the cTNT  promoter in  embryonic cardiac and skeletal 
muscle cells are different. 
Nonessential Upstream Regions have Similar Effects 
in Both Cardiac and Skeletal Muscle Cells 
Our deletion experiments also indicate that inclusion of two 
upstream  regions can  affect the activity of the  minimum 
cTNT promoter segments in the two cell types. While neither 
region is required for the activity of the minimum segments, 
the effect of each region is similar in both cell types. One of 
these, residing between positions -550 and -269, increases 
the level of expression of the minimum cTNT promoter ap- 
proximately threefold in both skeletal and cardiac muscle 
cells (Fig. 6). Inclusion of the upstream region between posi- 
tions -3,000 and -550 appears to have a negative effect on 
CAT expression, essentially abolishing the apparent positive 
effect conferred by the -550/-269  region. Negative-acting 
upstream sequences have been found in many genes (7, 22, 
26, 42, 52, 54), although their role in vivo is not yet clear. 
The magnitude of the effects that these two upstream regions 
have  upon  CAT  activity,  although  reproducible,  is  quite 
small which raises the possibility that these effects are ar- 
tifactual interactions between cTNT upstream sequences and 
host vector sequences which can affect the activity of pas- 
senger promoters. 
When the  -550/-269  region is placed upstream of the 
HSV tk promoter, in a pUC-based plasmid vector, it is also 
able  to  potentiate CAT  expression approximately two- to 
threefold, in a position- and orientation-independent manner 
(Fig. 3).  The magnitude of this effect is similar to that ob- 
served for this segment in its native position within the cTNT 
upstream region (Fig. 6).  Moreover, the potentiating effect 
is observed in skeletal muscle cells, but not in fibroblast cells 
(Fig. 3, b and c). These results are consistent with the con- 
clusion that the  -550/-269  region contains a muscle spe- 
cific transcriptional enhancer. Preliminary experiments sug- 
gest a similar potentiating effect in cardiac cultures (data not 
shown)  but are  complicated in their interpretation by the 
preferential transfection of non-myocardial cells in these ex- 
periments. Nevertheless, the relatively modest effects of the 
putative enhancer (-550/-269)  and negative:acting  (-3,000/ 
-550) regions indicate that further work will be required to 
unequivocally define their roles, if any, in the regulation of 
the cTNT promoter in cardiac and skeletal muscle cells. 
Sequences Controlling  Tissue Specificity of the 
cTNT Promoter 
Transfection of the cTNT-CAT genes into embryonic cardiac 
and skeletal muscle cells demonstrated that the activities of 
minimal active promoter segments are about two orders of 
magnitude higher than in fibroblast cells (Table III). There- 
fore, a high degree of cell specificity resides within the mini- 
mum promoter segments defined by these experiments.  How- 
ever, when the upstream DNA is extended to position -550 
(cTNT-550) expression in cardiac and skeletal muscle cells 
is over 400-  and 700-fold higher than in  fibroblast cells. 
Thus, the presence of the -550/-269 segment has a modest 
quantitative effect upon the level of expression, as well as a 
modest qualitative effect upon the degree of cell specificity. 
As noted above, such modest effects from upstream segments 
can be difficult to discern from spacing effects. Nevertheless, 
in experiments with heterologous promoters, the potentiat- 
ing effect of the -550/-269 segment appears to be cell spe- 
cific. The overall cell specificity of the cTNT promoter may 
therefore result from a combination of effects from separate 
domains. Such combinatorial activity of upstream elements 
has been shown to be important for cell specific expression 
of  the vertebrate insulin, chymotrypsin (15, 63) and immuno- 
globulin (29, 46) genes. Moreover, the multiple cell speci- 
ficities of the mouse alpha fetoprotein gene are determined 
by the combinatorial interaction of multiple upstream en- 
hancers, each carrying a different cell tropism (21, 32).  In 
Drosophila, the tissue and/or stage specific expression of the 
white (43, 57), hsp26 (lO),fushi tarazu (35), and yolk protein 
genes (20) has also been shown to be controlled by multiple 
upstream sequences. The cTNT gene differs from the above 
examples in that the contribution of upstream regions is nei- 
ther  strong  nor  required  for cell  specific function of the 
cTNT minimum promoter segments defined here. We con- 
clude, therefore, that the cell specificity of the cTNT pro- 
moter  is  predominantly attributable to cis  elements con- 
tained within its minimal promoter regions (Fig. 6 b), and 
that elements residing farther upstream play a possibly sig- 
nificant, but secondary role. 
Different Regulatory Programs Govern the cTNT 
Gene in Cardiac and Skeletal Muscle Cells 
The minimum upstream region required for transcription of 
the cTNT gene promoter in embryonic skeletal muscle cells 
is not sufficient for transcription in cardiac cells. Expression 
in cardiac cells requires the presence of additional upstream 
DNA which is not required for expression in skeletal muscle 
cells. This finding does not support the conclusion that co- 
expression of genes in embryonic cardiac and skeletal mus- 
cle cells reflects commonality in gene regulatory programs. 
Therefore, during their evolutionary divergence from a com- 
mon ancestral cell type, one or both cell types has acquired 
novel regulatory programs for governing expression of the 
cTNT gene, and possibly other genes which are expressed 
in common during development. 
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